This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Hyundai Motor Company, Kia Corporation, Toolgen Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 20,267 
1 out of 5,750 
1 out of 23 Years Active: 2022-2026
Title: Innovations of Kang In Lee
Introduction
Kang In Lee is a prominent inventor based in Seoul, South Korea. He is known for his contributions to the field of genetic engineering, particularly through his work with CRISPR technology. His innovative approach has led to significant advancements in genome manipulation and editing.
Latest Patents
Kang In Lee holds a patent for a "Target-specific CRISPR mutant." This invention relates to an artificially engineered CRISPR/Cas9 system. More specifically, it involves an artificially engineered CRISPR enzyme that has enhanced target specificity. The application of this invention includes genome and epigenome manipulation or modification, genome targeting, genome editing, and in vitro diagnosis.
Career Highlights
Kang In Lee is associated with Toolgen Inc., a company that focuses on developing CRISPR technology for various applications. His work has positioned him as a key figure in the field of genetic research and innovation.
Collaborations
Some of his notable coworkers include Young-Hoon Kim and Min Hee Jung. Their collaborative efforts contribute to the ongoing advancements in CRISPR technology and its applications.
Conclusion
Kang In Lee's innovative work in CRISPR technology exemplifies the potential of genetic engineering to transform various fields. His contributions continue to pave the way for future advancements in genome editing and manipulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile